Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now displays a recruitment-closed notice ('No longer looking for participants') and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the page revision tag to v3.6.0 and standardizes the Intervention/Treatment label.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page's revision label has been updated to Revision: v3.5.5, replacing Revision: v3.5.4. This indicates an update to the page's underlying documents or templates.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.5.4 is now shown, replacing the previous revision v3.5.3; this denotes a minor version update to the page rather than a content change.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change in the site release rather than the underlying study information.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check79 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.